Okay, y'all.. I've heard from different people and for many months that TMJI (Bob CHristensen) has been stopped from creating patient-specific joints (and some people say the stock joints) anymore by the FDA. I have to post it here: THIS IS NOT TRUE.
I have been corresponding f...
-
TMJ implants
Diane D
Friday, May 04, 2007 at 11:18 PMre: TMJ implants
Anonymous
Sunday, October 12, 2008 at 11:38 AM -
Daine
Angi Harrover
Saturday, May 05, 2007 at 12:35 AMHey I am in the same boat as well and the meds that help me well for pain is the Duragesic patches helped me get my life back. And Soma for the muscles and ambien sometimes to help me sleep. I also use Norco for breakthrough pain. I would ask your pain clinic about trying the duragesic patches you change them either every 48 or 72 hrs. Beats taking pills 24/7 and hurting your tummy. Get rid of the Neurontin all it does is make you sleepy and makes you feel bad and gain weight trust me I was on it for 3 years. As soon as I got off of it I felt so much better. If you want to chat please send me an email angiharrover@gmail.com or find my share post Angi_H is me.
Angi
reply -
Meds for TMJ pain (well, other chronic pain, too)
annebeckett
Saturday, May 05, 2007 at 02:54 PMHi, Diane. The meds I've been on for many years, are tylenol-4 and soma. Also, to prevent migraines and vomiting, I take phenergan. My neuro tried Lyrica with me, too. After more than a week, I ended up with severe chest pains (I had a heart condition as a kid and prolly should have not started on it). However, the Lyrica did help me to sleep and it seems to help a lot of people. I don't think that this drug, alone, would be sufficient but, I am NOT a doctor; and, everyone responds differently to pain.
I would, like Angi said, go to a pain clinic and let them know what has helped in the past. The lyica; you've got to take some time, usually at least a week, for it to start to work.
reply -
FDA Warning Letter
Anonymous
Saturday, May 05, 2007 at 05:05 PMAdditional information can be located at:
<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />
<?xml:namespace prefix = v ns = "urn:schemas-microsoft-com:vml" />Department of Health and Human Services
Public Health Service
Food and Drug Administration9200 Corporate Boulevard
Rockville, Maryland 20850
<!-- #EndEditable --><!-- #BeginEditable "body" -->
DEC 2 0 2006WARNING LETTER
VIA FEDERAL EXPRESS
Robert W. Christensen, D.D.S.
President
TMJ Implants, Inc.
17301 W. Colfax Avenue
Suite 135
Golden, Colorado 80401Dear Dr. Christensen:
On September 5, 2006, the Food and Drug Administration (FDA) obtained information from your Internet web site, http://www.tmj.com, that revealed you are promoting hemi and full mandibles without premarket clearance or approval from FDA.
According to your web site, TMJ Implants, Inc. "can design and deliver hemi and full mandibles to meet the most unique and unusual patient needs. These highly specific oral maxillofacial surgical (OMS) reconstruction solutions allow patients enhanced function and greater pain reduction." You further claim, for example, that:
· TMJ Implants, Inc. has created solutions for such unusual conditions as Treacher- Collins and Goldenhar Syndromes"; and
· Unusual cases involving trauma to the mandible and/or temporomandibular joint (TMJ), and disease states such as cancer or tumor have also been addressed."
Under section 201(h) of the Federal Food, Drug, and Cosmetic Act (the Act), the hemi and full mandibles are devices because they are intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, or are intended to affect the structure or any function of the body, 21 U.S.C. 321(h). A review of our records reveals that you have not obtained marketing approval or clearance before you began offering your products for sale, which is a violation of the law. We are aware that you have received marketing approval for the TMJ (Temporomandibular Joint) Metal-on-Metal Total Joint Replacement System TM, which is intended for reconstruction of the TMJ due to one or more of the following conditions:
· Inflammatory arthritis involving the TMJ not responsive to other modalities of treatment
· Recurrent fibrous and/or bony ankylosis not responsive to other modalities of treatment
· Failed tissue graft
· Failed alloplastic joint reconstruction
· Loss of vertical mandibular height and/or occlusal relationship due to bone resorption, trauma, developmental relationship due to bone resorption, trauma, developmental abnormality, or pathologic lesion;
and for the Fossa-Eminence Prosthesis, which is intended for use to partially reconstruct the TMJ under the same conditions indicated for:
· the total joint replacement except for the last condition listed above and
· internal derangement confirmed to be pathological in origin by both clinical observation and radiographic findings, where the patient has moderate to severe pain and/or disabling dysfunction and has not responded to less invasive conventional therapy. You have not obtained approval for hemi and full mandibles that are intended for the uses described on your web site. You must obtain approval of either a new PMA or a supplement to one of your approved PMAs for these devices before they may be legally marketed.
The hemi and full mandibles are adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. 351(f)(1)(B), because you do not have an approved application for premarket approval (PMA) in effect pursuant to section 515(a) of the Act, 21 U.S.C. 360e(a), or an approved application for an investigational device exemption under section 520(g) of the Act, 21 U.S.C. 360j(g). The devices are also misbranded under section 502(o) the Act, 21 U.S.C. 352(o), because you did not notify the agency of your intent to introduce the devices into commercial distribution, as required by section 510(k) of the Act, 21 U.S.C. 360(k). For a device requiring premarket approval, the notification required by section 510(k) of the Act, 21 U.S.C. 360(k); is deemed satisfied when a PMA is pending before the agency (21 CFR 807.81(b)).
You should take prompt action to correct these deviations. Failure to promptly correct these deviations may result in regulatory action being initiated by the Food and Drug Administration without further notice. These actions include, but are not limited to, seizure, injunction, and/or civil money penalties. Also, Federal agencies are advised of the issuance of all Warning Letters about devices so that they may take this information into account when considering the award of contracts.
Please let this office know in writing what steps you have taken to correct the problem within fifteen (15) working days from the date you received this letter. We also ask that you explain how you plan to prevent this from happening again. In addition we request that you submit to our office distribution information for these devices for the past two years. If you need more time, let us know why and when you expect to complete your correction. Please direct your response or any questions you may have to:
Mr. Ronald L. Swann
Chief
Dental, Ear, Nose Throat, and
Ophthalmic Devices Branch (HFZ-331)
Division of Enforcement A
Office of Compliance
Center for Devices and Radiological Health
U.S. Food and Drug Administration
2098 Gaither Road
Rockville, Maryland 20850
U.S.A.If you have any questions about the content of this letter please contact Mr. Swann by phone at <?XML:NAMESPACE PREFIX = SKYPE />240-276-0115 or by fax at 240-276-0114.
Finally, you should understand that there are many FDA requirements pertaining to the manufacture and marketing of devices. This letter pertains only to the issue of premarket review for your device and does not necessarily address other obligations you have under
the law.Sincerely yours,
/S/
Timothy A. Ulatowski
Director
Office of Compliance
Center for Devices and
Radiological Health
reply -
Untitled Comment
Synergy
Saturday, May 05, 2007 at 05:23 PMWOW! Thanks for the information… but let’s be fair here… there was a posted reply to that letter and nothing has been decided. There is a PMA for patient specific devices in place. We all have different opinions about what it is best. What works for one, may or may not work for another!<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" ?>
I am so glad I caught this…..
December 28, 2006
Mr. Ronald L. Swann, Chief
Dental, Ear, Nose Throat, and Ophthalmic Devices Branch (HFZ-331)
Division of Enforcement A
Office of Compliance
Center for Devices and Radiological Health
U.S. Food and Drug Administration
2098 Gaither Road
Rockville, Maryland 20850Re: Warning Letter for Information Appearing on TMJI's Website.
Dear Mr. Swann:
This is a reply to the Warning Letter sent to me by Mr. Timothy Ulatowski dated December 20, 2006, received by our office on December 26, 2006 concerning the referenced matter.
First of all, I want to state for the record that we feel we are in total compliance with the terms and conditions of the prior PMA approval for the use of our Metal-on-Metal Total TMJ Replacement System™ and for the Fossa-Eminence Prosthesis in this situation.
We are sorry if there is a misconception on our website concerning the promotion of our Patient-Specific™ devices, which give the impression that we are "promoting hemi and full mandibles without pre-market clearance or approval from the FDA"
In attempting to reach the public with the awareness of the ability of our Patient-Specific™ full and partial TMJ devices to address complicated conditions that have no other means of solution because of such things as developmental abnormalities which include the Treacher-Collins and Goldenhar Syndromes and other situations of pathological lesion or origin, we should have made it clear that these unusual TMJ conditions are adaptable to treatment with our uniquely designed Patient-Specific™ TMJ devices
Obviously, we do not want to give the impression that we are in the business of"promoting hemi and full mandibles" when our business is the manufacture of devices needed for solving problems with the TMJ.
We will accordingly correct our website to eliminate any doubt or confusion that our labeling reflected on our website is solely to indicate the use of our Patient-Specific™ TMJ devices to address the type of situations approved by the FDA in our PMA.
We hope that this explanation satisfactorily responds to your concerns, as we wish to be in full compliance with FDA's approval for these Patient-Specific™ situations. We will await your response to let us know of any further action which we need to take.
Sincerely yours,
TMJ IMPLANTS, INC.
reply -
Thanks for adding to what I had to say..
annebeckett
Sunday, May 06, 2007 at 02:47 PMAnd, by this, for clearing up any misunderstandings. I truly HOPE this has dispelled any rumors and that these rumor-mongers will cease!
Anne
reply





















reply